Shandong Boyuan Pharmaceutical&Chemical
301617
FORSTAR
835640
Cre8 Direct(Ningbo)Co.,Ltd.
300703
Minami Acoustics
301383
ASR Microelectronics
688220
CN Stock MarketDetailed Quotes
603915 Jiangsu Guomao Reducer
- 13.83
- +0.35+2.60%
Not Open Dec 11 15:00 CST
9.12BMarket Cap27.01P/E (TTM)
14.00High12.99Low322.59KlotVolume13.35Open13.48Pre Close434.69MTurnover4.91%Turnover Ratio23.05P/E (Static)659.09MShares16.2952wk High2.54P/B9.08BFloat Cap7.6252wk Low14.83Limit Up656.63MShs Float34.98Historical High12.13Limit Down7.49%Amplitude7.31Historical Low0.32Dividend TTM13.48Avg Price146.57KlotAsk2.31%Div YieldTTM100Lot Size161.12KlotBid
Jiangsu Guomao Reducer Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -4.17%1.93B | -5.29%1.27B | -6.48%585.21M | -1.35%2.66B | -1.12%2.01B | -0.59%1.34B | 2.62%625.73M | -8.41%2.7B | -9.95%2.03B | -9.09%1.35B |
| Operating revenue | -4.17%1.93B | -5.29%1.27B | -6.48%585.21M | -1.35%2.66B | -1.12%2.01B | -0.59%1.34B | 2.62%625.73M | -8.41%2.7B | -9.95%2.03B | -9.09%1.35B |
| Other operating revenue | ---- | -8.61%17.24M | ---- | 0.81%29.6M | ---- | 29.54%18.87M | ---- | -6.89%29.37M | ---- | -21.01%14.57M |
| Total operating cost | -0.13%1.72B | -1.82%1.12B | -3.22%519.24M | -0.77%2.26B | -1.06%1.72B | -1.53%1.14B | 0.02%536.52M | -7.66%2.28B | -7.98%1.74B | -7.45%1.16B |
| Operating cost | 0.09%1.49B | -1.50%969.57M | -1.12%450.64M | -0.37%1.97B | -1.30%1.48B | -1.18%984.31M | -0.07%455.74M | -7.93%1.98B | -8.59%1.5B | -9.03%996.02M |
| Operating tax surcharges | -7.65%16.5M | -0.81%11.24M | -4.46%5.48M | -5.25%23.27M | -4.03%17.87M | -2.53%11.33M | 20.09%5.73M | 60.95%24.56M | 83.79%18.62M | 98.79%11.63M |
| Operating expense | -8.48%56.59M | -13.46%36.97M | -16.47%17.2M | -2.61%73.3M | 6.07%61.83M | 6.78%42.72M | 21.68%20.59M | -19.33%75.26M | -15.50%58.29M | -14.38%40.01M |
| Administration expense | -1.94%73.2M | -7.46%47.97M | 2.99%23.25M | -20.25%78.42M | -0.29%74.65M | -0.17%51.83M | -9.74%22.57M | -8.59%98.34M | -13.07%74.87M | -10.67%51.92M |
| Financial expense | 83.75%-2.52M | 85.14%-1.86M | 54.82%-1.36M | 39.00%-8.84M | -65.51%-15.52M | -132.57%-12.5M | -117.70%-3.01M | -128.92%-14.49M | -95.33%-9.38M | -52.38%-5.38M |
| -Interest expense (Financial expense) | 746.09%1.09M | 680.96%961.89K | 589.36%183.25K | 87.91%1.61M | -81.54%128.41K | -72.46%123.17K | -47.69%26.58K | 445.31%857.76K | 464.24%695.43K | 416.08%447.18K |
| -Interest Income (Financial expense) | 71.63%-4.57M | 75.77%-3.13M | 46.17%-1.72M | 31.44%-11.05M | -51.21%-16.12M | -107.81%-12.93M | -92.94%-3.19M | -114.22%-16.12M | -89.10%-10.66M | -53.39%-6.22M |
| Research and development | -9.00%86.64M | -10.74%58.3M | -31.13%24.03M | 6.08%127.01M | 5.13%95.21M | -1.83%65.32M | -0.50%34.89M | 6.40%119.73M | 10.69%90.56M | 27.71%66.53M |
| Credit Impairment Loss | 35.67%-13.71M | 29.36%-14.07M | 39.71%-8.25M | -271.63%-3.5M | -89.61%-21.31M | -52.34%-19.92M | -32.04%-13.68M | 116.65%2.04M | 42.95%-11.24M | 34.06%-13.07M |
| Asset Impairment Loss | 48.26%-8.4M | 72.99%-3.71M | 143.39%1.43M | 28.38%-18.38M | -58.31%-16.25M | -163.24%-13.75M | -19.48%-3.3M | -264.62%-25.66M | -781.06%-10.26M | -376.04%-5.22M |
| Other net revenue | 1,683.31%27.64M | 307.34%18.46M | 340.95%5.97M | 23.18%41.82M | -108.44%-1.75M | -203.25%-8.91M | 55.50%-2.48M | -14.19%33.95M | 2.83%20.69M | -16.00%8.63M |
| Fair value change income | ---1.69K | ---3.11K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Invest income | 10.22%31.25M | 39.51%25.26M | -25.30%7.15M | -7.11%42.55M | -24.80%28.35M | -24.06%18.1M | 63.71%9.57M | -13.26%45.8M | 10.93%37.71M | -5.19%23.84M |
| -Including: Investment income associates | -69.46%3.43M | -43.08%3.92M | -58.33%1.69M | -29.58%14.28M | -36.93%11.24M | -28.75%6.89M | 91.56%4.05M | -5.25%20.28M | 23.05%17.82M | 8.53%9.66M |
| Asset deal income | 98.75%-18.05K | 94.04%-31.88K | 84.66%-29.65K | -14,660.65%-1.57M | -10,313.66%-1.44M | -3,892.14%-535.24K | ---193.32K | 100.96%10.76K | 102.50%14.11K | 102.69%14.11K |
| Other revenue | 108.21%18.52M | 53.31%11.02M | 10.44%5.66M | 93.25%22.72M | 99.32%8.89M | 134.51%7.19M | 199.35%5.13M | 64.11%11.76M | -8.49%4.46M | -14.33%3.07M |
| Operating profit | -17.95%238.39M | -12.10%164.25M | -17.05%71.94M | -2.43%440.69M | -8.46%290.56M | -4.00%186.86M | 28.01%86.73M | -12.44%451.67M | -18.83%317.39M | -18.07%194.65M |
| Add:Non operating Income | 64.51%3.42M | 51.72%2.24M | 51.66%872.02K | 7.01%3.78M | -64.22%2.08M | -42.44%1.48M | -55.76%574.99K | -48.43%3.53M | 168.40%5.81M | 191.46%2.56M |
| Less:Non operating expense | 1,797.72%1.22M | 12,391.17%626.41K | 3,239.60%3.32K | 10.14%137.74K | -40.98%64.08K | 36.80%5.01K | -73.57%99.35 | -34.40%125.05K | -42.84%108.58K | -98.06%3.67K |
| Total profit | -17.76%240.6M | -11.93%165.86M | -16.60%72.81M | -2.36%444.34M | -9.45%292.57M | -4.50%188.33M | 26.43%87.3M | -12.90%455.07M | -17.79%323.09M | -17.23%197.2M |
| Less:Income tax cost | 5.27%29.62M | 9.06%19.43M | 10.92%8.34M | 18.17%51.06M | -16.16%28.14M | -1.84%17.81M | 60.45%7.52M | -30.39%43.21M | -29.21%33.56M | -38.67%18.15M |
| Net profit | -20.22%210.98M | -14.13%146.43M | -19.19%64.47M | -4.51%393.27M | -8.67%264.43M | -4.77%170.52M | 23.95%79.78M | -10.54%411.86M | -16.22%289.54M | -14.20%179.06M |
| Net profit from continuing operation | -20.22%210.98M | -14.13%146.43M | -19.19%64.47M | -4.51%393.27M | -8.67%264.43M | -4.77%170.52M | 23.95%79.78M | -10.54%411.86M | -16.22%289.54M | -14.20%179.06M |
| Less:Minority Profit | 226.72%2.4M | 115.26%131.99K | 70.83%-177.63K | -9.65%-2.23M | -3.91%-1.89M | 35.34%-864.87K | -81.95%-608.89K | -23.43%-2.03M | -331.99%-1.82M | -326.91%-1.34M |
| Net profit of parent company owners | -21.68%208.58M | -14.64%146.3M | -19.59%64.65M | -4.44%395.5M | -8.59%266.33M | -4.99%171.39M | 24.25%80.39M | -10.42%413.9M | -15.50%291.36M | -13.31%180.4M |
| Earning per share | ||||||||||
| Basic earning per share | -24.39%0.31 | -15.38%0.22 | -16.67%0.1 | -4.76%0.6 | -6.82%0.41 | -3.70%0.26 | 20.00%0.12 | -11.27%0.63 | -16.98%0.44 | -15.63%0.27 |
| Diluted earning per share | -24.39%0.31 | -15.38%0.22 | -16.67%0.1 | -4.76%0.6 | -6.82%0.41 | -3.70%0.26 | 20.00%0.12 | -11.27%0.63 | -16.98%0.44 | -15.63%0.27 |
| Other composite income | -41.58%62.1K | 79.92%-35.78K | -115.77%-9.81K | 148.02%169.71K | 126.47%106.3K | 4.59%-178.21K | 196.88%62.21K | -529.00%-353.38K | -2,543.23%-401.66K | -848.34%-186.77K |
| Other composite income of parent company owners | -41.58%62.1K | 79.92%-35.78K | -115.77%-9.81K | 148.02%169.71K | 126.47%106.3K | 4.59%-178.21K | 196.88%62.21K | -529.00%-353.38K | -2,543.23%-401.66K | -848.34%-186.77K |
| Total composite income | -20.22%211.04M | -14.06%146.4M | -19.27%64.46M | -4.39%393.44M | -8.51%264.54M | -4.77%170.34M | 24.01%79.84M | -10.63%411.51M | -16.34%289.13M | -14.30%178.87M |
| Total composite income of parent company owners | -21.69%208.64M | -14.57%146.27M | -19.66%64.64M | -4.32%395.67M | -8.43%266.43M | -4.99%171.21M | 24.31%80.45M | -10.51%413.54M | -15.62%290.95M | -13.41%180.21M |
| Total composite income of minority owners | 226.72%2.4M | 115.26%131.99K | 70.83%-177.63K | -9.65%-2.23M | -3.91%-1.89M | 35.34%-864.87K | -81.95%-608.89K | -23.43%-2.03M | -331.99%-1.82M | -326.91%-1.34M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
